X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (3) 3
gastroenterology & hepatology (3) 3
humans (3) 3
index medicus (3) 3
male (3) 3
medical prognosis (3) 3
patients (3) 3
survival (3) 3
1st-line therapy (2) 2
abridged index medicus (2) 2
adult (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer (2) 2
cancer therapies (2) 2
care and treatment (2) 2
chemotherapy (2) 2
comparative analysis (2) 2
deoxycytidine - adverse effects (2) 2
deoxycytidine - analogs & derivatives (2) 2
deoxycytidine - therapeutic use (2) 2
female (2) 2
gemcitabine (2) 2
human health and pathology (2) 2
irinotecan (2) 2
life sciences (2) 2
medicine, general & internal (2) 2
metastases (2) 2
metastasis (2) 2
middle aged (2) 2
multicenter (2) 2
open-label (2) 2
oxaliplatin (2) 2
pancreatic cancer (2) 2
pancreatic neoplasms - drug therapy (2) 2
proportional hazards models (2) 2
quality of life (2) 2
resection (2) 2
usage (2) 2
1st-line treatment (1) 1
5-fluorouracil (1) 1
[sdv.mhep.csc]life sciences [q-bio]/human health and pathology/cardiology and cardiovascular system (1) 1
[sdv.mhep.me]life sciences [q-bio]/human health and pathology/emerging diseases (1) 1
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
[sdv.mp.bac]life sciences [q-bio]/microbiology and parasitology/bacteriology (1) 1
[sdv.mp.par]life sciences [q-bio]/microbiology and parasitology/parasitology (1) 1
[sdv.mp.vir]life sciences [q-bio]/microbiology and parasitology/virology (1) 1
acute disease (1) 1
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
aged, 80 and over (1) 1
amlodipine - adverse effects (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
bacteriology (1) 1
biology (1) 1
biomarkers (1) 1
biopsy (1) 1
blood (1) 1
brivanib (1) 1
calcium channel blockers - adverse effects (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - analogs & derivatives (1) 1
carcinoma (1) 1
cardiology and cardiovascular system (1) 1
cardiovascular disease (1) 1
cell biology (1) 1
chemical and drug induced liver injury - diagnosis (1) 1
chemotherapy, adjuvant (1) 1
chemotherapy, combination (1) 1
circulating tumor cells (1) 1
circulating tumor dna (1) 1
clinical trials (1) 1
clinical-trials (1) 1
colorectal cancer (1) 1
colorectal carcinoma (1) 1
combination (1) 1
cooperative-oncology-group (1) 1
cytotoxicity (1) 1
deoxyribonucleic acid--dna (1) 1
diarrhea (1) 1
disease-free survival (1) 1
double-blind (1) 1
drug combinations (1) 1
drug therapy (1) 1
emerging diseases (1) 1
fees & charges (1) 1
fluorouracil (1) 1
fluorouracil - administration & dosage (1) 1
fluorouracil - adverse effects (1) 1
fluorouracil - therapeutic use (1) 1
folfirinox (1) 1
follow-up studies (1) 1
gastroenterology (1) 1
gemcitabine plus oxaliplatin (1) 1
grants (1) 1
hcc (1) 1
hepatocellular carcinoma (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2011, Volume 364, Issue 19, pp. 1817 - 1825
In this study, a four-drug combination chemotherapy regimen was associated with objective responses in more than 30% of patients and increased survival by more... 
PHASE-III TRIAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | SOLID TUMORS | CLINICAL-TRIALS | IRINOTECAN | OXALIPLATIN | 1ST-LINE THERAPY | COMBINATION | CARCINOMA | COOPERATIVE-ONCOLOGY-GROUP | Leucovorin - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Camptothecin - analogs & derivatives | Severity of Illness Index | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Quality of Life | Aged | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Chemotherapy, Combination | Usage | Care and treatment | Gemcitabine | Pancreatic cancer | Leucovorin | Comparative analysis | Drug therapy | Fluorouracil | Clinical trials | Cytotoxicity | Pancreas | Patients | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 25, pp. 2395 - 2406
Journal Article
by Merle, Philippe and Blanc, Jean-Frederic and Phelip, Jean-Marc and Pelletier, Gilles and Bronowicki, Jean-Pierre and Touchefeu, Yann and Pageaux, Georges and Gerolami, René and Habersetzer, François and Nguyen-Khac, Eric and Casadei-Gardini, Andrea and Borbath, Ivan and Tran, Albert and Wege, Henning and Saad, Amr Shafik and Colombo, Massimo and Abergel, Armand and Richou, Carine and Waked, Imam and Yee, Nelson S and Molé, Audrey and Attali, Pierre and Le Boulicaut, Julie and Vasseur, Bérangère and Moussata, Driffa and Grangé, Jean-Didier and Ratziu, Vlad and Khemissa-Akouz, Faiza and Regnault, Hélène and Dauvois, Barbara and Zarski, Jean-Pierre and Ollivier-Hourmand, Isabelle and Manfredi, Sylvain and Debette-Gratien, Marilyne and Gangloff, Alice and Fontanges, Thierry and Baron, Aurore and Bouattour, Mohamed and Vincent, Julie and Sieghart, Wolfgang and Maieron, Andreas and Peeters, Marc and Delwaide, Jean and Lasser, Luc and Berg, Thomas and Schultheiß, Michael and Zipprich, Alexander and Trojan, Joerg and Ehmer, Ursula and Luppi, Gabriele and Luca, Giovanni and Tamberi, Stefano and Amoroso, Domenico and Alabiso, Oscar and Buonadonna, Angela and Toniutto, Pierluigi and Tamburini, Emiliano and Cubillo, Antonio and Muñoz, Andrés and Guillén, Carmen and Sánchez, Gloria and Manzano, Hermini and Navarro, Victor and Ales, Inmaculada and Massuti, Bartomeu and Dank, Magdolna and Bodoky, György and Kahan, Zsuzsanna and Horváth, Zsolt and Gabrail, Nashat and Ozer, Howard and Galanopoulos, Christos and Hauke, Ralph and Raj, Moses and Harputluoglu, Hakan and Sevinc, Alper and Goker, Erdem and Coker, Ahmet and Yalcin, Suayib and Ali, Muhammet and Ata, Ozlem and Tugba, Ilkay and ElKassas, Mohammed and Abdel, Amr and Wakid, Imam and Shamaa, Sameh and El, Nasr and Kohail, Hanaa and Makarem, Jawad and Chehade, Issam and Farhat, Fadi and López, Carlos and Marín, Miguel and RELIVE Investigators
The Lancet Gastroenterology and Hepatology, ISSN 2468-1253, 06/2019, Volume 4, Issue 6, pp. 454 - 465
Background: Cytotoxic chemotherapy is generally ineffective in patients with hepatocellular carcinoma. We assessed the intravenous perfusion of... 
MULTICENTER | PLACEBO | DOUBLE-BLIND | OPEN-LABEL | BRIVANIB | 1ST-LINE THERAPY | GASTROENTEROLOGY & HEPATOLOGY | GEMCITABINE PLUS OXALIPLATIN
Journal Article
Gastroenterologie Clinique et Biologique, ISSN 0399-8320, 2002, Volume 26, Issue 6-7, pp. 637 - 638
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.